SEC Form 4 · accession 0001179110-15-003817
HOSPIRA INC · HSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew R Stober
Officer — SVP, Operations
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2015 | M | 11,111 | $42.70 | A | 98,911 | D | |
| Common Stock | Feb 26, 2015 | S | 11,111 | $87.46 | D | 87,800 | D | |
| Common Stock | Feb 27, 2015 | M | 14,227 | $28.95 | A | 102,027 | D | |
| Common StockF5 | Feb 27, 2015 | S | 14,227 | $87.476 | D | 87,800 | D | |
| Common Stock | Feb 27, 2015 | F | 1,449 | $87.49 | D | 86,351 | D | |
| Common Stock | Feb 27, 2015 | F | 2,254 | $87.54 | D | 84,097 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $42.70 | Feb 26, 2015 | M | 11,111 | A | Feb 26, 2015 | Feb 25, 2021 | Common Stock | 11,111 | 33,333 | D |
| Stock Option (Right to Buy)F4 | $28.95 | Feb 27, 2015 | M | 14,227 | A | Feb 27, 2015 | Feb 26, 2020 | Common Stock | 14,227 | 28,457 | D |
Explanation of responses
- F1Payment of tax liability by withholding securities incident to the vesting of the restricted stock units (granted February 27, 2013).
- F2Exercise of derivative security exempted pursuant to Rule 16b-3.
- F3The stock options vest in three equal annual installments on February 26, 2015, 2016 and 2017. The exercise price of $42.70 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on February 25, 2021.
- F4The stock options vest in three equal annual installments on February 27, 2014, 2015 and 2016. The exercise price of $28.950 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on February 26, 2020.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.47 to $87.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
Remarks
Traded pursuant to a 10b5-1 plan.